Neuronano AB approaching the clinical phase
Neuronano AB – a med tech company spun out of NanoLund and the Neuronano Research Center (NRC) – recently issued new shares, according to the news service Rapidus. 20 MSEK are taking the company closer to the clinical phase. Treating diseases with biocompatible electrodes small enough to leave as little imprint on the brain tissue as possible – that’s the business concept for Neuronano AB. The fir
https://www.nano.lu.se/article/neuronano-ab-approaching-clinical-phase - 2025-12-29
